The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 260.00
High: 260.00
Low: 260.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

23 Jan 2017 07:00

RNS Number : 7780U
Spectra Systems Corporation
23 January 2017
 

Spectra Systems Corporation

("The Company" or "Spectra Systems")

Appointment of Chief Financial Officer

Spectra Systems, a leading supplier of authentication technology for banknotes, brand authentication and tax stamps, is delighted to announce that, subject to the satisfactory conclusion of due diligence, it has agreed to appoint Brian E McLain C.P.A. (aged 41) as its new Chief Financial Officer.

Brian McLain started his career in 1997 at Arthur Andersen prior to working as a senior accountant at Excelergy Corporation, a software business, located in Lexington, MA from 2000 until 2003. Until late 2006, he then progressed through various roles at International Power, a UK owned power producer located in Marlborough MA, prior to joining SeraCare Life Sciences, Inc, a manufacturer of biological products for the diagnostics and drug discovery markets located in Milford MA. At SeraCare, which was quoted on NASDAQ prior to being bought out in 2012, he progressed from the role of Corporate Controller to Vice President, Finance & Business Solutions. In 2014, he then joined OMNIlife Science Inc., a manufacturer and distributor of orthopaedic devices located in Raynham, MA, in the role of Corporate Controller.

A further announcement will be made upon the conclusion of due diligence by certain of Spectra's customers and the completion of standard regulatory AIM background checks. This due diligence is expected to be completed by no later than February 2017. In the meantime, Doug Anderson, the previous Chief Financial Officer is continuing to assist Spectra as necessary.

Brian McLain joined SeraCare Life Sciences Inc. ("SeraCare") in January 2007, at which point it was already in a bankruptcy process. All creditors were subsequently settled and SeraCare exited the bankruptcy process. There are no other matters which are required to be announced pursuant to paragraph (g) of Schedule 2 to the AIM Rules.

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "I am delighted to welcome Brian to Spectra Systems and believe that his extensive financial experience in both private and public businesses as well as his experience in technology driven companies will be of immense value to us."

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEFFWSFWSEFF
Date   Source Headline
26th Jul 20127:00 amRNSShareholder Circular Posted
11th Jul 20127:00 amRNSDepositary Interest Facility & Admission to CREST
29th Jun 20124:17 pmRNSAnnual Financial Report
25th Jun 20127:00 amRNSStatement re share price movement
6th Jun 20127:00 amRNSAcquisition
19th Apr 20127:00 amRNSFinal Results
10th Apr 20127:00 amRNSNotice of Results
14th Feb 20127:00 amRNSDirectorate Change
10th Feb 20127:00 amRNSDirectorate Change
30th Sep 20117:00 amRNSInterim Results for the 6 months ended 30 Jun 2011
4th Aug 20117:00 amRNSShareholder Notifications
1st Aug 20117:00 amRNSShareholder Notifications
25th Jul 20117:00 amRNSFirst Day of Dealings on AIM
30th Apr 20097:51 amRNSNet Asset Value(s)
29th Apr 20097:41 amRNSNet Asset Value(s)
28th Apr 20097:48 amRNSNet Asset Value(s)
27th Apr 20098:04 amRNSNet Asset Value(s)
24th Apr 20097:42 amRNSNet Asset Value(s)
23rd Apr 20097:36 amRNSNet Asset Value(s)
22nd Apr 20097:48 amRNSNet Asset Value(s)
21st Apr 20097:38 amRNSNet Asset Value(s)
20th Apr 20097:49 amRNSNet Asset Value(s)
17th Apr 20098:08 amRNSNet Asset Value(s)
16th Apr 20098:09 amRNSNet Asset Value(s)
15th Apr 20098:03 amRNSNet Asset Value(s)
14th Apr 20098:00 amRNSNet Asset Value(s)
14th Apr 20097:00 amRNSNet Asset Value(s)
9th Apr 20097:52 amRNSNet Asset Value(s)
8th Apr 20097:59 amRNSNet Asset Value(s)
7th Apr 20097:57 amRNSNet Asset Value(s)
6th Apr 20098:20 amRNSNet Asset Value(s)
3rd Apr 20097:49 amRNSNet Asset Value(s)
2nd Apr 20097:50 amRNSNet Asset Value(s)
1st Apr 20097:48 amRNSNet Asset Value(s)
31st Mar 20097:51 amRNSNet Asset Value(s)
30th Mar 20097:49 amRNSNet Asset Value(s)
27th Mar 20098:00 amRNSNet Asset Value(s)
26th Mar 20097:54 amRNSNet Asset Value(s)
25th Mar 20097:39 amRNSNet Asset Value(s)
24th Mar 20098:46 amRNSNet Asset Value(s)
23rd Mar 20097:55 amRNSNet Asset Value(s)
20th Mar 20098:12 amRNSNet Asset Value(s)
19th Mar 20097:59 amRNSNet Asset Value(s)
18th Mar 20097:45 amRNSNet Asset Value(s)
17th Mar 20098:00 amRNSNet Asset Value(s)
16th Mar 20099:28 amRNSTotal Redemption
16th Mar 20098:03 amRNSNet Asset Value(s)
13th Mar 20097:58 amRNSNet Asset Value(s)
12th Mar 20097:55 amRNSNet Asset Value(s)
9th Mar 20097:58 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.